ReviewPharmaceuticals (Basel, Switzerland)2025

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

Ming-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.